The patient with localized Hodgkin's disease is curable. Evidence from numerous centers indicates that vigorous local therapy has yielded long-term survivors with 10, 15, and 20 years free of disease. The main consideration is which form of therapy the patient should receive. As Slaughter has indicated, radical surgical excision of peripheral adenpoathy has been successful; however, the irradiation which he used postoperatively in 50% of his cases reflects doubt as to whether or not the disease focus was fully removed. When we view the figures which Lacher2recently reported when he compared the survival rates obtained from irradiation alone with those obtained from surgery (65.6% versus 63.6% five-year survivals), we must seriously question whether or not surgery should be extended beyond excisional biopsy of peripheral adenopathy for diagnosis. In six of the seven survivors in Lacher's surgically treated group, irradiation before or after operations was also required. The careful